| Autor: |
Sweet KL; Moffitt Cancer Center, Tampa, Florida., Cortes JE; Georgia Cancer Center, Augusta University, Augusta, Georgia., Apperley JF; Centre for Haematology, Imperial College, London, United Kingdom., Mann M; Patient Advocate, Jonesboro, Georgia., Mauro MJ; Myeloproliferative Neoplasms Program, Memorial Sloan Kettering Cancer Center, New York City, New York., Oehler VG; Fred Hutchinson Cancer Research Center, Seattle Cancer Care Alliance, Seattle, Washington., Ruiz C; Patient Advocate, Jonesboro, Georgia., Schiffer CA; Department of Hematology-Oncology, Karmanos Cancer Center at Wayne State University, Detroit, Michigan., Ehrlich LA; Center for Drug Evaluation and Research, FDA, Washington, District of Columbia., Pamuk GE; Center for Drug Evaluation and Research, FDA, Washington, District of Columbia., Wynne J; Center for Drug Evaluation and Research, FDA, Washington, District of Columbia., Mehta GU; Center for Drug Evaluation and Research, FDA, Washington, District of Columbia., Okusanya OO; Center for Drug Evaluation and Research, FDA, Washington, District of Columbia., de Claro RA; Center for Drug Evaluation and Research, FDA, Washington, District of Columbia., Theoret MR; Oncology Center of Excellence, FDA, Washington, District of Columbia., Smith BD; The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, Maryland., Norsworthy KJ; Center for Drug Evaluation and Research, FDA, Washington, District of Columbia. |
